Algert Global LLC Increases Stock Holdings in Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat
9 hours ago • Google News
Arvinas Inc (ARVN)
US$ 9.038.8%
Price Chart
Key Statistics
Market Cap
$ 482.47M
P/E Ratio
0.00
Revenue (TTM)
$ 426.9M
Volume
7.96M
52W High
$ 37.38
52W Low
$ 5.93
Dividend Yield
0.00%
Beta
2.23
Technicals
50-Day MA
9.6516
200-Day MA
19.9028
52 Week High
37.38
52 Week Low
5.935
About ARVN
Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.
Employees
430
Headquarters
New Haven, CT
CEO
Dr. John G. Houston Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg